283 related articles for article (PubMed ID: 8964239)
41. Pharmacokinetics of flunixin meglumine in the cow.
Hardee GE; Smith JA; Harris SJ
Res Vet Sci; 1985 Jul; 39(1):110-2. PubMed ID: 4035085
[TBL] [Abstract][Full Text] [Related]
42. PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (
East B; Tell L; Citino SB; Fredholm DV; Gamble K; Fajt V
J Zoo Wildl Med; 2019 Jun; 50(2):322-329. PubMed ID: 31260196
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in ICR mice.
Ogino T; Arai T
Exp Anim; 2007 Apr; 56(2):79-84. PubMed ID: 17460352
[TBL] [Abstract][Full Text] [Related]
44. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus).
Leavens TL; Tell LA; Kissell LW; Smith GW; Smith DJ; Wagner SA; Shelver WL; Wu H; Baynes RE; Riviere JE
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(9):1506-21. PubMed ID: 25082521
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of naproxen in the dog.
Frey HH; Rieh B
Am J Vet Res; 1981 Sep; 42(9):1615-7. PubMed ID: 7325471
[TBL] [Abstract][Full Text] [Related]
46. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and pharmacodynamics of cefovecin in dogs.
Stegemann MR; Sherington J; Blanchflower S
J Vet Pharmacol Ther; 2006 Dec; 29(6):501-11. PubMed ID: 17083454
[TBL] [Abstract][Full Text] [Related]
48. PHARMACOKINETICS OF ORALLY ADMINISTERED FLUNIXIN MEGLUMINE IN AFRICAN (
Bechert U; Christensen JM; Kottwitz J; Boothe D; Alshahrani S; Mohammed S
J Zoo Wildl Med; 2021 Jan; 51(4):905-914. PubMed ID: 33480571
[TBL] [Abstract][Full Text] [Related]
49. A physiologically based pharmacokinetic model linking plasma protein binding interactions with drug disposition.
Buur JL; Baynes RE; Smith GW; Riviere JE
Res Vet Sci; 2009 Apr; 86(2):293-301. PubMed ID: 18721993
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of flunixin in chickens after oral and intravenous administration.
Musser JM
J Vet Pharmacol Ther; 2010 Jun; 33(3):312-4. PubMed ID: 20557449
[No Abstract] [Full Text] [Related]
51. Absorption and distribution of naproxen in rats orally treated with naproxen betainate sodium salt monohydrate. Comparison with naproxen.
Marzo A; Ripamonti M; Benatti P; Marzo P; Wool C; Cerutti R; Reiner V
Arzneimittelforschung; 1997 Apr; 47(4):381-4. PubMed ID: 9150857
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits.
Elmas M; Yazar E; Uney K; Er Karabacak A; Traş B
Vet J; 2008 Sep; 177(3):418-24. PubMed ID: 17644374
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves.
Semrad SD; McClure JT; Sams RA; Kaminski LM
Am J Vet Res; 1993 Nov; 54(11):1906-12. PubMed ID: 8291771
[TBL] [Abstract][Full Text] [Related]
54. A study to assess the correlation between plasma, oral fluid and urine concentrations of flunixin meglumine with the tissue residue depletion profile in finishing-age swine.
Bates JL; Karriker LA; Rajewski SM; Lin Z; Gehring R; Li M; Riviere JE; Coetzee JF
BMC Vet Res; 2020 Jun; 16(1):211. PubMed ID: 32571315
[TBL] [Abstract][Full Text] [Related]
55. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Foreman JH; Ruemmler R
Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
[TBL] [Abstract][Full Text] [Related]
56. [Interaction of salicyl compounds and other non-steroidal anti-inflammatory agents: pharmacokinetic study of phenylbutazone-aspirin combination in man].
Gaucher A; Netter P; Faure G; Tamisier JN; Pourel J; Maillard A; Royer RJ
Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):425-9. PubMed ID: 781789
[TBL] [Abstract][Full Text] [Related]
57. Carprofen in veterinary medicine. I. Plasma disposition, milk excretion and tolerance in milk-producing cows.
Ludwig B; Jordan JC; Rehm WF; Thun R
Schweiz Arch Tierheilkd; 1989; 131(2):99-106. PubMed ID: 2928755
[TBL] [Abstract][Full Text] [Related]
58. Effect of age on the pharmacokinetics and pharmacodynamics of flunixin meglumine following intravenous and transdermal administration to Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; Smith JS; KuKanich B; Rajewski SM; Walsh P; Perkins S; Coetzee JF
Am J Vet Res; 2018 May; 79(5):568-575. PubMed ID: 29688783
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows.
Kleinhenz MD; Gorden PJ; Smith JS; Schleining JA; Kleinhenz KE; Wulf LL; Sidhu PK; Rea D; Coetzee JF
J Vet Pharmacol Ther; 2018 Jun; 41(3):490-493. PubMed ID: 29460288
[TBL] [Abstract][Full Text] [Related]
60. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
Lees P; Giraudel J; Landoni MF; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
